Gord Davey - Delivra Health CEO President
DHB Stock | 0.20 0.01 5.26% |
CEO
Gord Davey is CEO President of Delivra Health Brands
Address | 999 Canada Place, Vancouver, BC, Canada, V6C 3E2 |
Phone | 604 449 9280 |
Web | https://delivrahealthbrands.com |
Delivra Health Management Efficiency
The company has return on total asset (ROA) of (0.115) % which means that it has lost $0.115 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0337) %, meaning that it generated substantial loss on money invested by shareholders. Delivra Health's management efficiency ratios could be used to measure how well Delivra Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.01 in 2025. Return On Capital Employed is likely to climb to -2.08 in 2025. At this time, Delivra Health's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 10 M in 2025, whereas Intangible Assets are likely to drop slightly above 1 M in 2025.Similar Executives
Found 5 records | CEO Age | ||
William Hullah | FTI Foodtech International | N/A | |
Noam Ftecha | Plantify Foods | N/A | |
PEng Eng | Cogeco Communications | 59 | |
Philippe Jette | Cogeco Communications | 54 | |
Richard Kellam | Data Communications Management | 59 |
Management Performance
Return On Equity | -0.0337 | ||||
Return On Asset | -0.11 |
Delivra Health Brands Leadership Team
Elected by the shareholders, the Delivra Health's board of directors comprises two types of representatives: Delivra Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Delivra. The board's role is to monitor Delivra Health's management team and ensure that shareholders' interests are well served. Delivra Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Delivra Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gord Davey, CEO President | ||
Ann Gallery, Senior Communications | ||
CPA CMA, CFO Secretary | ||
Matthew Wagar, Senior Innovation | ||
Will Stewart, Sr Affairs | ||
CPA CGA, VP Fin | ||
Jonathan Hartshorn, President Satipharm | ||
Frank MBA, Independent Chairman |
Delivra Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Delivra Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0337 | ||||
Return On Asset | -0.11 | ||||
Profit Margin | (0.01) % | ||||
Operating Margin | (0.09) % | ||||
Current Valuation | 4.99 M | ||||
Shares Outstanding | 31.26 M | ||||
Shares Owned By Insiders | 11.43 % | ||||
Shares Owned By Institutions | 1.86 % | ||||
Number Of Shares Shorted | 1.01 K | ||||
Price To Book | 1.49 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Delivra Stock Analysis
When running Delivra Health's price analysis, check to measure Delivra Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Delivra Health is operating at the current time. Most of Delivra Health's value examination focuses on studying past and present price action to predict the probability of Delivra Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Delivra Health's price. Additionally, you may evaluate how the addition of Delivra Health to your portfolios can decrease your overall portfolio volatility.